At a glance
- Originator Nissan Chemical Industries; Zeria
- Class Antiallergics; Antiasthmatics; Pyridazines; Small molecules
- Mechanism of Action Leukotriene D4 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma
Most Recent Events
- 08 Jul 1998 Discontinued-I for Asthma in Japan (Unknown route)